Cosette Pharmaceuticals Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
350
- Latest Deal Type
-
Debt
- Financing Rounds
-
4
- Investments
-
9
Cosette Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended for women in dermatology and allergy. The company specializes in a portfolio of branded pharmaceuticals consisting of products in women's health, cardiology and dermatology products which includes creams, ointments, lotions, solutions, gels, pastes, suppositories and oral liquids through end-to-end capabilities in product development and commercial operations, enabling clients to meet their dermatology and allergy drug needs.
Contact Information
Website
www.cosettepharma.comCorporate Office
- 200 Crossing Boulevard
- 4th Floor
- Bridgewater, NJ 08807
- United States
Corporate Office
- 200 Crossing Boulevard
- 4th Floor
- Bridgewater, NJ 08807
- United States
Cosette Pharmaceuticals Timeline
Cosette Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cosette Pharmaceuticals Comparisons
Industry
Financing
Details
Cosette Pharmaceuticals Competitors (15)
One of Cosette Pharmaceuticals’s 15 competitors is Almirall, a Corporation company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Almirall | Corporation | Barcelona, Spain | ||||
| Encube Ethicals | Private Equity-Backed | Mumbai, India | ||||
| Padagis | Private Equity-Backed | Allegan, MI | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ |
Cosette Pharmaceuticals Patents
Cosette Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12558347-B2 | Cevimeline liquid formulations | Active | 30-Jul-2024 | ||
| US-20260034060-A1 | Cevimeline liquid formulations | Pending | 30-Jul-2024 | ||
| US-20260034108-A1 | Cevimeline liquid formulations | Active | 30-Jul-2024 | ||
| US-20260191776-A1 | Cevimeline liquid formulations | Pending | 30-Jul-2024 | ||
| EP-4132517-B1 | Dantrolene for use in the treatment of viral infections | Active | 10-Apr-2020 | A61K31/4178 |
Cosette Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cosette Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cosette Pharmaceuticals Investments (9)
Cosette Pharmaceuticals’s most recent deal was a Buyout/LBO with Sympazan. The deal was made on 08-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sympazan | 08-Apr-2026 | Buyout/LBO | Pharmaceuticals | ||
| Sanofi (Ambien and Ambien CR) | 10-Jul-2024 | Buyout/LBO | Buildings and Property | ||
| Palatin Technologies (Vyleesi) | 19-Dec-2023 | Buyout/LBO | Buildings and Property | ||
| Endoceutics (108 Issued and Pending Patents Across the Globe) | 08-Jun-2023 | Buyout/LBO | Buildings and Property | ||
| Endoceutics | 23-May-2023 | Buyout/LBO | Drug Discovery |
Cosette Pharmaceuticals Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cosette Pharmaceuticals Nc Laboratories | Lincolnton, NC | 2014 | |
| Sympazan | Warren, NJ |
Cosette Pharmaceuticals FAQs
-
When was Cosette Pharmaceuticals founded?
Cosette Pharmaceuticals was founded in 2019.
-
Where is Cosette Pharmaceuticals headquartered?
Cosette Pharmaceuticals is headquartered in Bridgewater, NJ.
-
What is the size of Cosette Pharmaceuticals?
Cosette Pharmaceuticals has 350 total employees.
-
What industry is Cosette Pharmaceuticals in?
Cosette Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Cosette Pharmaceuticals a private or public company?
Cosette Pharmaceuticals is a Private company.
-
What is Cosette Pharmaceuticals’s current revenue?
The current revenue for Cosette Pharmaceuticals is .
-
How much funding has Cosette Pharmaceuticals raised over time?
Cosette Pharmaceuticals has raised $165M.
-
Who are Cosette Pharmaceuticals’s investors?
Hamilton Lane Advisors and Avista Healthcare Partners have invested in Cosette Pharmaceuticals.
-
Who are Cosette Pharmaceuticals’s competitors?
Almirall, Encube Ethicals, Padagis, Glenmark Pharmaceuticals, and Amneal Pharmaceuticals are some of the 15 competitors of Cosette Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
